Global Ganja Report

A House bill to legalize cannabis, removing it from the Controlled Substances Act and treating it like alcohol, is wryly dubbed HR 420. It isn't the first such bill in Congress—but with the recent change in House leadership, this time it may actually stand a chance of passing.

A Chinese delegation to Israel to explore cooperation in the cannabis sector points to the East Asian giant's growing footprint in the global industry. But in a continued contradiction, the People's Republic has possibly the harshest drug laws on Earth—and, where unsanctioned use by the commoners is concerned, cannabis is no exception.

In a win both for cannabis freedom and racial justice, Vermont's top court ruled in favor of a motorist whose car was searched on the ostensible basis that a state trooper smelled pot—and the probable basis that he is African American.

In a strange irony, Vancouver is shutting down its long-tolerated but unlicensed cannabis dispensaries, pursuant to a British Columbia high court decision upholding its right to do so—even as the province struggles to meet demand amid a dearth of licensed retail outlets.

The claim that cannabis causes "mental illness" rears its dubious head like clockwork every few years, and this latest round has occasioned a virtual media frenzy—a seeming backlash to the recent advances in normalization of the herb and its aficionados. Scratching the claims, however, reveals more hype than rigor.

The headlines are all too familiar ones, but this time they got very prominent play.

In Episode 24 of the CounterVortex podcast, Bill Weinberg notes the historic strides toward liberation of the cannabis plant in 2018, from the fabled four corners of the Earth. Yet under capitalism, every advance also opens new contradictions.

With Trump's demands for Congressional funding to build his border wall having forced a shut-down of the federal government, a new report suggests that cannabis legalization has actually done more than security measures to reduce illegal drug flows from Mexico—and that this reality holds lessons for the immigration dilemma.

With passage of the Farm Bill and removal of hemp-derived CBD from controlled substance status, big market growth is expected for the very chic and purportedly salubrious non-psychoactive cannabinoid. The law is a win for a nascent CBD industry that has been struggling to shake off the lingering stigma surrounding (psychoactive) cannabis. The effort to segment cannabidiol from "marijuana" is exemplified in the several states that now have "CBD-only" laws.